Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: Apr 1, 2011

Premium

NIH Grants in Proteomics, Oct. 22 to March 23, Part 2 of 2

Title: Renewal of the UMDNJ Neuroproteomics Core Facility
Contact Principal Investigator: Hong Li
Organization: University of Medicing/Dentistry of NJ-NJ Medical School
Project Start Date: Dec. 1, 2010
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $702,000


Title: Gene-Environment Interactions in an Autism Birth Cohort
Contact Principal Investigator: Ian Lipkin
Organization: Columbia University Health Sciences
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $3,183,066


Title: Identifying Antigens Bound by Novel SCFVS Targeting All Subtypes of Mesothelioma
Contact Principal Investigator: Bin Liu
Organization: University of California San Francisco
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $288,529


Title: Instrumentation for Analysis of High Mass Biomolecules
Contact Principal Investigator: Scott Mcluckey
Organization: Purdue University West Lafayette
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $204,805


Title: Identification of New Markers and Drug Target Candidates for Triple Negative Breast Cancer
Contact Principal Investigator: Metodi Metodiev
Organization: University of Essex
Project Start Date: Jan. 7, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $49,327


Title: Proteomic and Lipidomic Profiling of Tumor-Derived Exosomes for Cancer Prevention
Contact Principal Investigator: Robert Moritz
Organization: Institute for Systems Biology
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $85,900


Title: Healthy Aging and Senile Dementia
Contact Principal Investigator: John Morris
Organization: Washington University
Project Start Date: Feb. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $1,325,749


Title: 2011 US-HUPO Conference -- Proteomics: New Developments and Grand Challenges
Contact Principal Investigator: David Muddiman
Organization: North Carolina State University Raleigh
Project Start Date: March 18, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $15,000


Title: 2011 US-HUPO Conference -- Proteomics: New Developments and Grand Challenges
Contact Principal Investigator: David Muddiman
Organization: North Carolina State University Raleigh
Project Start Date: March 18, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $5,000


Title: 2011 US-HUPO Conference -- Proteomics: New Developments and Grand Challenges
Contact Principal Investigator: David Muddiman
Organization: North Carolina State University Raleigh
Project Start Date: March 18, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $5,000


[ pagebreak ]

Title: Development and Application of New Ionization Methods for Biological Mass Spectrometry
Contact Principal Investigator: David Muddiman
Organization: North Carolina State University Raleigh
Project Start Date: Sep.1, 2010
Project End Date: July 31, 2011
FY Total Cost by IC: $31,010


Title: Revealing the HIV-1 Interactome
Contact Principal Investigator: Mark Muesing
Organization: Aaron Diamond AIDS Research Center
Project Start Date: Feb. 1, 2011
Project End Date: Jan. 31, 2012
FY Total Cost by IC: $406,519


Title: Population-Based Proteomic Investigation of Type 2 Diabetes Mellitus
Contact Principal Investigator: Randall Nelson
Organization: Arizona State University-Tempe Campus
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $564,453


Title: Crosstalk Between the Ubiquitin and Sumo Pathways in Genome Stability
Contact Principal Investigator: Minghua Nie
Organization: Scripps Research Institute
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $52,154


Title: Pathways of Maternal Anemia
Contact Principal Investigator: Andrew Oleinikov
Organization: Seattle Biomedical Research Institute
Project Start Date: Dec. 1, 2010
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $540,067


Title: Epigenetic Regulation in Self-Renewing and Differentiating Male Germ Cells
Contact Principal Investigator: Christopher Payne
Organization: Children's Memorial Hospital (Chicago)
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $224,101


Title: Molecular Epidemiology and Lung Cancer: A Nested Case-Control Study
Contact Principal Investigator: Frederica Perera
Organization: Columbia University Health Sciences
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $384,849


Title: Proteomic Analyses of Clostridium Difficile Spore Germination Apparatus
Contact Principal Investigator: David Popham
Organization: Virginia Polytechnic Institute and State University
Project Start Date: March 1, 2011
Project End Date: Feb. 28, 2012
FY Total Cost by IC: $202,988


Title: A Protein-Protein Interaction Map of Escherichia Coli
Contact Principal Investigator: Seesandra Rajagopala
Organization: J. Craig Venter Institute
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $561,806


Title: Mechanism of Peroxiredoxin 3 in a Model of Pesticide-Mediated Neurodegeneration
Contact Principal Investigator: James Roede
Organization: Emory University
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $50,352


[ pagebreak ]

Title: Liquid Array Protein Assay Platform
Contact Principal Investigator: David Rothwarf
Organization: Arrayomics
Project Start Date: March 1, 2011
Project End Date: Feb. 28, 2012
FY Total Cost by IC: $631,188


Title: Engineered Proteases for Proteomics
Contact Principal Investigator: Biao Ruan
Organization: Potomac Affinity Proteins
Project Start Date: Feb. 1, 2011
Project End Date: Jan. 31, 2012
FY Total Cost by IC: $353,557


Title: Products of the Transforming Genes of Polyomavirus
Contact Principal Investigator: Brian Schaffhausen
Organization: Tufts University
Project Start Date: Jan. 14, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $412,500


Title: Interaction Pattern Based Predictor of Protein Structure
Contact Principal Investigator: Jeffrey Skolnick
Organization: Georgia Institute of Technology
Project Start Date: Feb. 1, 2011
Project End Date: Jan. 31, 2012
FY Total Cost by IC: $262,355


Title: Cognitive Decline & Protein Expression Profiles in Aging
Contact Principal Investigator: William Sonntag
Organization: University of Oklahoma Health Sciences Center
Project Start Date: Feb. 1, 2011
Project End Date: Jan. 31, 2012
FY Total Cost by IC: $334,345


Title: Notch and Stem Cells in Lung Cancer Treated with Erlotinib Plus Notch Inhibitor
Contact Principal Investigator: David Stewart
Organization: University of Texas MD Anderson Cancer Center
Project Start Date: March 2, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $253,472


Title: Proteomic Studies of Dendrimer-Based Nanomedicines
Contact Principal Investigator: Weiguo Tao
Organization: Purdue University
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $166,231


Title: Cognitive Dysfunction after Chronic Cocaine
Contact Principal Investigator: Jane Taylor
Organization: Yale University
Project Start Date: Dec. 1, 2010
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $254,700


Title: Mucosal Immune and Bacterial Characterization in Chronic Laryngitis
Contact Principal Investigator: Susan Thibeault
Organization: University of Wisconsin Madison
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $471,970


Title: Analysis of Candida Albicans Filamentation Using SILAC
Contact Principal Investigator: Derek Thomas
Organization: Grand Valley State University
Project Start Date: Feb. 15, 2011
Project End Date: Jan. 31, 2012
FY Total Cost by IC: $57,464


[ pagebreak ]

Title: Energy Restrction and Mammary Cancer
Contact Principal Investigator: Henry Thompson
Organization: Colorado State University-Fort Collins
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $290,717


Title: Plug-And-Play, Sensor-Based, NanoLC/ESI Technology for Proteomics and Glycomics
Contact Principal Investigator: Colleen Van Pelt
Organization: Corsolutions
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $400,000


Title: High Resolution MALDI-TOF Mass Spectrometer
Contact Principal Investigator: Marvin Vestal
Organization: Virgin Instruments
Project Start Date: March 1, 2011
Project End Date: Feb. 28, 2012
FY Total Cost by IC: $361,525


Title: A S. Cerevisiae High-Coverage High-Quality Protein-Protein Binary Interactome Map
Contact Principal Investigator: Marc Vidal
Organization: Dana-Farber Cancer Institute
Project Start Date: Feb. 17, 2011
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $790,000


Title: Dynamics of Cardiac Nuclei in Heart Disease
Contact Principal Investigator: Thomas Vondriska
Organization: University of California Los Angeles
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $385,000


Title: Development and Application of Endogenous Epitope Tagging Technology
Contact Principal Investigator: Todd Waldman
Organization: Georgetown University
Project Start Date: March 1, 2011
Project End Date: Feb. 29, 2012
FY Total Cost by IC: $180,286


Title: Protein Recognition for Modular Domains
Contact Principal Investigator: Wei Wang
Organization: University of California San Diego
Project Start Date: Dec. 1, 2010
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $263,346


Title: Glycoregulation of SKP1 in the Cytoplasm and Nucleus
Contact Principal Investigator: Christopher West
Organization: University of Oklahoma Health Sciences Center
Project Start Date: Dec. 1, 2010
Project End Date: Nov. 30, 2011
FY Total Cost by IC: $344,478


Title: Chlamydia Trachomatis Proteomics
Contact Principal Investigator: Guangming Zhong
Organization: University of Texas Health Science Center San Antonio
Project Start Date: Jan. 18, 2011
Project End Date: Dec. 31, 2011
FY Total Cost by IC: $371,250

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.